je.st
news
Tag: cancer study
Study claims red meat triggers cancer; 5 resources say otherwise
2015-03-25 21:07:18| Beef
A University of California study claims red meat causes a toxic immune reaction that eventually leads to cancer. Here are five resources that say otherwise. Share these on social media today, and lets start a grassroots conversation about how red meat is part of a healthy diet. Content Classification: Curated BEEF Daily read more
Tags: resources
red
study
otherwise
International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer
2014-12-10 14:45:00| Merck.com - Research & Development News
Dateline City: SAN ANTONIO Collaborative Trial is First to Investigate an Anti-PD-1 Therapy, Pembrolizumab, Combined with Trastuzumab Study to Explore Whether New Approach May Reverse Trastuzumab Resistance in Cancer with Significant Unmet Need SAN ANTONIO--(BUSINESS WIRE)--The International Breast Cancer Study Group (IBCSG), Breast International Group (BIG), and Merck, known as MSD outside the United States and Canada, today announced the opening of the PANACEA study, a global collaborative study exploring a new way to treat HER2+ breast cancer that has become resistant to the current standard of care. Language: English Contact: International Breast Cancer Study GroupLaura Cava Northrop, 617-632-3973press@ibcsg.orgorBreast International GroupCecilia Waldvogel, +41 79 478-0238cecilia.waldvogel@BIGagainstbc.orgorMerckClaire Mulhearn, 908-236-1118claire.mulhearn@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: international
group
study
opening
Modified measles virus targets and destroys cancer, study says
2014-05-17 09:14:28| Biotech - Topix.net
Can an injection of the measles cure cancer? In a recent clinical trial, researchers say that a genetically modified strain of the virus showed an ability to target and reduce tumors in a human patient.
Tags: study
modified
says
cancer
Study estimates 6% of lung cancer deaths in US and UK attributable to diesel exhaust
2013-11-28 15:30:15| Green Car Congress
Tags: to
study
cancer
estimates
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer
2013-10-29 06:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Phase II/III Trial of MK-3475 in Patients with NSCLC Currently Enrolling WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Language: English Contact: MerckMedia Contacts:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-500-1101orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more